Results 1 to 10 of about 31,380 (219)

Beliefs about hydroxyurea in youth with sickle cell disease

open access: yesHematology/ Oncology and Stem Cell Therapy, 2018
Background: Hydroxyurea reduces complications and improves health-related quality of life (HRQOL) in sickle cell disease (SCD) patients, however adherence remains suboptimal. Understanding patients’ views of hydroxyurea is critical to optimize adherence,
Sherif Badawy   +2 more
exaly   +3 more sources

Physiologically Based Pharmacokinetic Modelling of Hydroxyurea in Patients with Sickle Cell Disease: A Special Focus on Lactating Women and Breastfed Infants to Inform Safe Dosing and Breastfeeding Strategies [PDF]

open access: yesPharmaceuticals
Background/Objectives: Hydroxyurea is currently the standard disease-modifying therapy for reducing sickle cell disease (SCD) complications; however, drug labels currently advise discontinuation of breastfeeding during hydroxyurea therapy due to limited ...
Khaled Abduljalil   +3 more
doaj   +2 more sources

Hydroxyurea utilization among individuals with sickle cell disease in Tennessee: a pooled analysis of claims data [PDF]

open access: yesFrontiers in Pharmacology
ImportanceHydroxyurea reduces severe disease among individuals living with sickle cell disease (SCD). These individuals experience high acute care utilization, but the associations between patterns of hydroxyurea utilization and healthcare utilization ...
Ayesha Mukhopadhyay   +14 more
doaj   +2 more sources

Reversal of myelofibrosis by hydroxyurea [PDF]

open access: yesEuropean Journal of Haematology, 1990
Abstract: Bone marrow morphology in 39 symptomatic patients with myeloproliferative disorders (polycythaemia vera 15, essential thrombocythaemia 14, idiopathic myelofibrosis 9, myeloproliferative syndrome 1) and elevated platelet counts was studied before and after a median of 18 months of continuous treatment with hydroxyurea.
, A Ost
exaly   +3 more sources

Effect of treatment with hydroxyurea on calcium homeostasis in β-thalassemia-major patients

open access: yesAl-Azhar Assiut Medical Journal, 2021
Background and aim Thalassemia is a chronic illness that has a range of serious clinical and psychological effects, it does not only affect the physical functioning of patients but also their emotional and social functioning and school functionings ...
Khaled H Hassan
doaj   +1 more source

A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia

open access: yesScientific Reports, 2022
Hydroxyurea is an antimetabolite drug that induces fetal haemoglobin in sickle cell disease. However, its clinical usefulness in β-thalassaemia is unproven.
Nirmani Yasara   +11 more
doaj   +1 more source

Hydroxyurea

open access: yesCold Spring Harbor Protocols, 2006
europepmc   +3 more sources

Barriers to hydroxyurea use from the perspectives of providers, individuals with sickle cell disease, and families: Report from a U.S. regional collaborative

open access: yesFrontiers in Genetics, 2022
Sickle cell disease (SCD) is an inherited blood disorder that affects about 100,000 people in the U.S., primarily Blacks/African-Americans. A multitude of complications negatively impacts quality of life. Hydroxyurea has been FDA approved since 1998 as a
Marsha J. Treadwell   +14 more
doaj   +1 more source

Spermatogenesis in Mice exposed to Hydroxyurea: Protecitve effect of ntural apple cider vinegar [PDF]

open access: yesمجلة التربية والعلم, 2005
The effect of hydroxyurea at a close of 80mg/kg/day orally for (7) days on Spermatogenesis and the protective role of NACV (Natural apple cider vinegar) has been studied in mature male mice.
Aticka El-Nouri, Rafah Ayoub
doaj   +1 more source

Hydroxyurea pharmacokinetics and precision dosing in low-resource settings

open access: yesFrontiers in Molecular Biosciences, 2023
Introduction: Hydroxyurea is effective disease-modifying treatment for sickle cell anemia (SCA). Escalation to maximum tolerated dose (MTD) achieves superior benefits without additional toxicities, but requires dose adjustments with serial monitoring ...
Luke R. Smart   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy